Projects per year
The NORLUX Neuro-Oncology laboratory was set up through a collaborative agreement between LIH and the University of Bergen in Norway based on an extensive collaboration with Prof. Rolf Bjerkvig from the Department of Biomedicine at the University of Bergen. The mission of our lab is to improve the life and prognosis of people affected by a malignant brain tumor.
We aim to improve the treatment options for malignant brain tumors, with a focus on diffuse gliomas. With a radically translational approach to research, we work with patient samples and innovative patient-derived preclinical model systems that recapitulate the patient tumor. Our research investigates the cellular and molecular basis of gliomas, their capacity to invade the normal brain and escape therapy. Special areas of interests are tumor plasticity, tumor heterogeneity, tumor metabolism, immuno-oncology and pharmacogenomics.
Dive into details
Select a country/territory to view shared publications and projects
3/01/22 → 31/12/24
GLASS-LUX: Glioma Longitudinal AnalySiS in Luxembourg (GLASS-LUX): ex vivo and in vivo Functional Profiling of Recurrent Gliomas
1/09/21 → 31/08/24
1/06/21 → 31/05/23
Yabo, Y. A., Niclou, S. P. & Golebiewska, A., 4 May 2022, In: Neuro-Oncology. 24, 5, p. 669-682 14 p.
Research output: Contribution to journal › Review article › peer-reviewOpen Access2 Citations (Scopus)
Ilina, E. I., Cialini, C., Gerloff, D. L., Duarte Garcia-Escudero, M., Jeanty, C., Thézénas, M. L., Lesur, A., Puard, V., Bernardin, F., Moter, A., Schuster, A., Dieterle, M., Golebiewska, A., Gérardy, J. J., Dittmar, G., Niclou, S. P., Müller, T. & Mittelbronn, M., 18 Feb 2022, In: iScience. 25, 2, p. 103842 103842.
Research output: Contribution to journal › Article › peer-reviewOpen Access
& 259 others, , 22 Apr 2022.
Research output: Working paper › PreprintFile